FUKOKU MUTUAL LIFE INSURANCE Co Buys 1,181 Shares of Intuitive Surgical, Inc. $ISRG

FUKOKU MUTUAL LIFE INSURANCE Co increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 68.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,894 shares of the medical equipment provider’s stock after purchasing an additional 1,181 shares during the quarter. FUKOKU MUTUAL LIFE INSURANCE Co’s holdings in Intuitive Surgical were worth $1,639,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. Vanguard Group Inc. grew its stake in shares of Intuitive Surgical by 0.8% during the third quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock valued at $15,026,776,000 after purchasing an additional 263,828 shares during the last quarter. Capital World Investors boosted its stake in Intuitive Surgical by 1.5% in the third quarter. Capital World Investors now owns 7,728,492 shares of the medical equipment provider’s stock valued at $3,456,223,000 after acquiring an additional 116,034 shares during the last quarter. Fisher Asset Management LLC boosted its stake in Intuitive Surgical by 1.1% in the third quarter. Fisher Asset Management LLC now owns 3,889,439 shares of the medical equipment provider’s stock valued at $1,739,475,000 after acquiring an additional 40,702 shares during the last quarter. Amundi boosted its stake in Intuitive Surgical by 29.7% in the third quarter. Amundi now owns 3,227,472 shares of the medical equipment provider’s stock valued at $1,451,362,000 after acquiring an additional 739,444 shares during the last quarter. Finally, Jennison Associates LLC boosted its stake in Intuitive Surgical by 11.1% in the fourth quarter. Jennison Associates LLC now owns 3,209,137 shares of the medical equipment provider’s stock valued at $1,817,527,000 after acquiring an additional 321,759 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Insider Activity

In other Intuitive Surgical news, EVP Myriam Curet sold 105 shares of the stock in a transaction on Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total value of $51,864.75. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Amy L. Ladd sold 119 shares of the stock in a transaction on Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total transaction of $55,156.50. Following the completion of the sale, the director owned 120 shares in the company, valued at approximately $55,620. This trade represents a 49.79% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 5,481 shares of company stock valued at $2,673,871. 0.60% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Performance

ISRG opened at $423.63 on Friday. The firm’s fifty day moving average is $454.60 and its two-hundred day moving average is $507.01. The firm has a market cap of $150.03 billion, a PE ratio of 51.35, a price-to-earnings-growth ratio of 3.34 and a beta of 1.51. Intuitive Surgical, Inc. has a twelve month low of $414.30 and a twelve month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping the consensus estimate of $2.08 by $0.42. The company had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business’s revenue for the quarter was up 23.0% compared to the same quarter last year. During the same period last year, the business posted $1.81 earnings per share. Equities analysts forecast that Intuitive Surgical, Inc. will post 8.57 EPS for the current fiscal year.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical announced Taylor Patton will become Chief Commercial and Marketing Officer effective July 1, while current commercial chief Henry Charlton moves to SVP of Global Business Operations. The change appears to be an internal promotion, suggesting leadership continuity rather than disruption. Article Title
• Positive Sentiment: The company has also highlighted major updates to its da Vinci 5 robotic surgical system, with more than 100 improvements set to roll out to U.S. customers starting in June. Investors may view that as a sign of continued innovation and potential to support procedure growth. Article Title
• Positive Sentiment: Recent commentary from market and research outlets has remained favorable, with articles arguing that Intuitive Surgical’s above-average financial growth and optimistic analyst outlook could make the stock attractive to growth investors. Article Title
• Neutral Sentiment: A market note said Intuitive Surgical underperformed competitors on Wednesday, but the item did not point to a company-specific setback or new fundamental issue. Article Title

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the stock. Robert W. Baird raised their price objective on shares of Intuitive Surgical from $575.00 to $610.00 and gave the company an “outperform” rating in a research note on Wednesday, April 22nd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research note on Tuesday, May 19th. Leerink Partners reduced their price objective on shares of Intuitive Surgical from $622.00 to $573.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 22nd. Mizuho set a $525.00 price objective on shares of Intuitive Surgical and gave the company a “neutral” rating in a research note on Monday, April 13th. Finally, Evercore reduced their price objective on shares of Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating on the stock in a research note on Monday, April 6th. Nineteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $576.71.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.